Anti-Thymocyte Globulin (Rabbit)

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Stem Cell Transplantation in Crohn's Disease

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Haploidentical HCT for Severe Aplastic Anemia

Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Treg Modulation With CD28 and IL-6 Receptor Antagonists

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation

Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation